A Pilot Study of NT-I7, a Long-Acting Recombinant IL-7 Molecule, as an Immune Reconstitution Strategy for Lymphopenia in Patients With Progressive Multifocal Leukoencephalopathy
Latest Information Update: 19 Feb 2024
At a glance
- Drugs Efineptakin alfa (Primary)
- Indications Progressive multifocal leukoencephalopathy
- Focus Therapeutic Use
- 22 Dec 2022 Planned End Date changed from 31 Dec 2026 to 31 Jan 2026.
- 22 Dec 2022 Planned primary completion date changed from 31 Dec 2026 to 31 Jan 2026.
- 09 Feb 2022 Planned End Date changed from 31 Jan 2026 to 31 Dec 2026.